Der CJ - Search Results

1

Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer.

Goodwin CM, Waters AM, Klomp JE, Javaid S, Bryant KL, Stalnecker CA, Drizyte-Miller K, Papke B, Yang R, Amparo AM, Ozkan-Dagliyan I, Baldelli E, Calvert V, Pierobon M, Sorrentino JA, Beelen AP, Bublitz N, Lüthen M, Wood KC, Petricoin EF, Sers C, McRee AJ, Cox AD, Der CJ. Goodwin CM, et al. Among authors: der cj. Cancer Res. 2023 Jan 4;83(1):141-157. doi: 10.1158/0008-5472.CAN-22-0391. Cancer Res. 2023. PMID: 36346366 Free PMC article. Clinical Trial.

2

Protein prenylation: key to ras function and cancer intervention?

Khosravi-Far R, Cox AD, Kato K, Der CJ. Khosravi-Far R, et al. Among authors: der cj. Cell Growth Differ. 1992 Jul;3(7):461-9. Cell Growth Differ. 1992. PMID: 1419908 Review. No abstract available.

3

The ras/cholesterol connection: implications for ras oncogenicity.

Cox AD, Der CJ. Cox AD, et al. Among authors: der cj. Crit Rev Oncog. 1992;3(4):365-400. Crit Rev Oncog. 1992. PMID: 1420445 Review.

4

Protein prenylation: more than just glue?

Cox AD, Der CJ. Cox AD, et al. Among authors: der cj. Curr Opin Cell Biol. 1992 Dec;4(6):1008-16. doi: 10.1016/0955-0674(92)90133-w. Curr Opin Cell Biol. 1992. PMID: 1485954 Review.

5

Isoprenoid modification and plasma membrane association: critical factors for ras oncogenicity.

Der CJ, Cox AD. Der CJ, et al. Cancer Cells. 1991 Sep;3(9):331-40. Cancer Cells. 1991. PMID: 1751286 Review.

6

Transcriptional activation analysis of oncogene function.

Hauser CA, Der CJ, Cox AD. Hauser CA, et al. Among authors: der cj. Methods Enzymol. 1994;238:271-6. doi: 10.1016/0076-6879(94)38025-2. Methods Enzymol. 1994. PMID: 7799793

7

Biological assays for cellular transformation.

Cox AD, Der CJ. Cox AD, et al. Among authors: der cj. Methods Enzymol. 1994;238:277-94. doi: 10.1016/0076-6879(94)38026-0. Methods Enzymol. 1994. PMID: 7799794

8

R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells.

Cox AD, Brtva TR, Lowe DG, Der CJ. Cox AD, et al. Among authors: der cj. Oncogene. 1994 Nov;9(11):3281-8. Oncogene. 1994. PMID: 7936652

9

Oncogenic Ras activates c-Jun via a separate pathway from the activation of extracellular signal-regulated kinases.

Westwick JK, Cox AD, Der CJ, Cobb MH, Hibi M, Karin M, Brenner DA. Westwick JK, et al. Among authors: der cj. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6030-4. doi: 10.1073/pnas.91.13.6030. Proc Natl Acad Sci U S A. 1994. PMID: 8016110 Free PMC article.

10

The CAAX peptidomimetic compound B581 specifically blocks farnesylated, but not geranylgeranylated or myristylated, oncogenic ras signaling and transformation.

Cox AD, Garcia AM, Westwick JK, Kowalczyk JJ, Lewis MD, Brenner DA, Der CJ. Cox AD, et al. Among authors: der cj. J Biol Chem. 1994 Jul 29;269(30):19203-6. J Biol Chem. 1994. PMID: 8034681 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

382 results

Search Page